Immunome (IMNM) Current Deferred Revenue (2023 - 2025)

Immunome (IMNM) posted Current Deferred Revenue of $4.0 million for Q1 2025, down 42.16% on a QoQ basis from $6.9 million in Q4 2024, and down 68.5% year-over-year from $12.7 million in Q1 2024.

Immunome (IMNM) Current Deferred Revenue (2023 - 2025) Analysis & Trends

Immunome's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $4.0 million for Q1 2025.

  • Quarterly Current Deferred Revenue fell 68.5% year-over-year to $4.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $4.0 million (down 68.5% YoY) and the FY2024 annual result came in at $6.9 million, down 56.57% from the prior year.
  • Current Deferred Revenue was $4.0 million for Q1 2025 at Immunome, down from $6.9 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $27.6 million in Q1 2023 and bottomed at $4.0 million in Q1 2025.
  • A 3-year average of $14.4 million and a median of $12.7 million in 2024 frame the typical range for Current Deferred Revenue.
  • Annual changes were most pronounced in 2024 — Current Deferred Revenue sank 42.92% — and 2025, when it sank 68.5%.
  • Immunome's Current Deferred Revenue stood at $16.0 million in 2023, then slumped by 56.57% to $6.9 million in 2024, then sank by 42.16% to $4.0 million in 2025.
  • Business Quant data shows IMNM's Current Deferred Revenue at $4.0 million in Q1 2025, $6.9 million in Q4 2024, and $9.7 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Immunome 2.49 Bn 1.91 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2025 4.02 Mn
Dec 31, 2024 6.94 Mn
Sep 30, 2024 9.68 Mn
Jun 30, 2024 12.59 Mn
Mar 31, 2024 12.75 Mn
Dec 31, 2023 15.98 Mn
Sep 30, 2023 16.96 Mn
Jun 30, 2023 23.37 Mn
Mar 31, 2023 27.64 Mn